Your browser doesn't support javascript.
loading
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.
Licht, Christoph; Greenbaum, Larry A; Muus, Petra; Babu, Sunil; Bedrosian, Camille L; Cohen, David J; Delmas, Yahsou; Douglas, Kenneth; Furman, Richard R; Gaber, Osama A; Goodship, Timothy; Herthelius, Maria; Hourmant, Maryvonne; Legendre, Christophe M; Remuzzi, Giuseppe; Sheerin, Neil; Trivelli, Antonella; Loirat, Chantal.
Afiliación
  • Licht C; Division of Nephrology and Program in Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Greenbaum LA; Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Muus P; Department of Hematology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, USA.
  • Bedrosian CL; Alexion Pharmaceuticals, Inc., Cheshire, Connecticut, USA.
  • Cohen DJ; Department of Kidney and Pancreas Transplantation, Columbia University Medical Center, New York, New York, USA.
  • Delmas Y; Department of Nephrology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Douglas K; Beatson West Scotland Cancer Centre, Glasgow, UK.
  • Furman RR; Division of Hematology/Oncology, Weill Cornell Medical College, New York, New York, USA.
  • Gaber OA; Department of Surgery/Transplant Center, Houston Methodist Hospital, Houston, Texas, USA.
  • Goodship T; Department of Renal Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Herthelius M; Department of Clinical Science, Intervention and Technology (CLINTEC), H9, Karolinska University Hospital, Stockholm, Sweden.
  • Hourmant M; Department of Nephrology, CHU Hotel Dieu-Nantes, Nantes, France.
  • Legendre CM; Adult Kidney Transplant Unit, Université Paris Descartes & Hôpital Necker, Paris, France.
  • Remuzzi G; Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.
  • Sheerin N; Department of Nephrology, Newcastle University, Newcastle upon Tyne, UK.
  • Trivelli A; Department of Nephrology, Istituto Giannina Gaslini, Genova, Italy.
  • Loirat C; Department of Pediatric Nephrology, Assistance Publique-Hôpitaux de Paris, Hôpital Robert-Debré, Paris, France.
Kidney Int ; 87(5): 1061-73, 2015 May.
Article en En | MEDLINE | ID: mdl-25651368
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Síndrome Hemolítico Urémico Atípico Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Kidney Int Año: 2015 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Síndrome Hemolítico Urémico Atípico Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Kidney Int Año: 2015 Tipo del documento: Article País de afiliación: Canadá